Retraction to: 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

Carcinogenesis. 2022 Jun 27;43(6):611. doi: 10.1093/carcin/bgac038.
No abstract available

Publication types

  • Retraction of Publication